Sawgrass Asset Management LLC Vanda Pharmaceuticals Inc. Transaction History

Sawgrass Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$15.69 - $21.14 $323,684 - $436,118	-20,630 Closed	0 $0
Q3 2021 Nov 04, 2021	SELL	$15.35 - $21.27 $11,052 - $15,314	-720 Reduced 3.37%	20,630 $354,000
Q2 2021 Aug 05, 2021	BUY	$15.71 - $21.51 $136,519 - $186,921	8,690 Added 68.64%	21,350 $459,000
Q1 2021 Apr 29, 2021	BUY	$13.42 - $20.28 $18,922 - $28,594	1,410 Added 12.53%	12,660 $190,000
Q4 2020 Jan 22, 2021	BUY	$9.77 - $13.81 $109,912 - $155,362	11,250 New	11,250 $148,000

152

43.3M

33.8K

28.7K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $249M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Sawgrass Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Sawgrass Asset Management LLC with notifications on news.